Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Accounts Payables (2019 - 2025)

Historic Accounts Payables for Volitionrx (VNRX) over the last 9 years, with Q3 2025 value amounting to $3.1 million.

  • Volitionrx's Accounts Payables rose 2532.53% to $3.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year increase of 2532.53%. This contributed to the annual value of $2.8 million for FY2024, which is 1386.08% down from last year.
  • Per Volitionrx's latest filing, its Accounts Payables stood at $3.1 million for Q3 2025, which was up 2532.53% from $2.4 million recorded in Q2 2025.
  • In the past 5 years, Volitionrx's Accounts Payables ranged from a high of $3.5 million in Q1 2024 and a low of $1.1 million during Q2 2021
  • For the 5-year period, Volitionrx's Accounts Payables averaged around $2.6 million, with its median value being $2.9 million (2023).
  • Its Accounts Payables has fluctuated over the past 5 years, first skyrocketed by 14024.35% in 2022, then plummeted by 2977.79% in 2025.
  • Quarter analysis of 5 years shows Volitionrx's Accounts Payables stood at $1.5 million in 2021, then skyrocketed by 97.28% to $3.0 million in 2022, then increased by 5.53% to $3.2 million in 2023, then fell by 13.86% to $2.8 million in 2024, then rose by 12.59% to $3.1 million in 2025.
  • Its last three reported values are $3.1 million in Q3 2025, $2.4 million for Q2 2025, and $3.0 million during Q1 2025.